Editorial Board


Editorial Board Members

  • Fred Wyszkowski Cancer Research Laboratory, Technion - Israel Institute of Technology, Haifa, Israel.
  • Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
  • Oncology Department,Medway NHS Foundation Trust, Kent, UK
  • Institute of Experimental and Clinical Pharmacology, Christian Albrechts University Kiel, Hospitalstr. 4, Kiel, Germany.
  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Srl-IRCCS, Meldola, Italy.
  • Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA, USA.
  • Department of Pharmaceutical Biology, Institute of Biochemistry and Pharmacy, Johannes Gutenberg University, Staudinger Weg 5, Mainz, Germany.
  • Oncoclinica Group, Oncoclinical Institute, Rio de Janeiro, Brazil.
  • Department of Biomedical Sciences, Faculty of Medicine, University of Namur, Namur, Belgium.
  • Lab Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands; Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, Pisa, Italy.
  • Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
  • Cancer Biology Laboratory, Lutheran University of Brazil, Canoas, Brazil.
  • Clinical Pharmacy Group, Department of Pharmaceutical and Medical Chemistry, University of Münster, Münster, Germany.
  • Cell Death and Metabolism Unit, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Department of Rheumatology, Amsterdam Rheumatology and immunology Center (ARC), Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
  • Division of Medical Oncology, University of Basel, Basel, Switzerland.
  • Institute of Pharmacy, University of Bonn, Bonn, Germany.
  • Department of Urologic Oncology, Case Western Reserve University, Cleveland, Ohio, USA.
  • Faculty of Health Sciences, University of Macau, Macau, China.
  • Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
  • Faculty of Health and Medical Sciences, Department of Immunology & Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Srl-IRCCS, Meldola, Italy.
  • Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA.
  • School of Biosciences, University of Kent, Canterbury, UK.
  • Division of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.
  • Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy.
  • Molecular Pharmacology, School of Pharmaceutical Sciences (EPGL), University of Geneva, Geneva, Switzerland.
  • Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy.
  • School of Pharmacy, University of Huddersfield, Huddersfield, UK.
  • Department of Oncology, University of Torino Torino, Italy.
  • Department of Genetics, Physical Anthropology and Animal Physiology (School of Medicine) of the University of the Basque Country (UPV/EHU), Basque Country, Spain.
  • Nova Medical School (NMS), Universidade Nova de Lisboa/Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal.
  • Department of Clinical Haematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Australia.
  • Division of Pharmaceutics & Pharmaceutical Chemistry College of Pharmacy, The Ohio State University, Columbus, OH, USA.
  • Department of Biochemistry, University of Vermont Larner College of Medicine, Burlington, VT, USA.
  • Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité – Universitätsmedizin und Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany.
  • Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute, Atlanta, GA, USA.
  • Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
  • Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
  • Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.